VXRT

Vaxart Stock Price

6.10
0.18 (3.04%)
Upgrade to Real-Time
Afterhours (Closed)
6.10
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.18 3.04% 6.10 19:59:08
Open Price Low Price High Price Close Price Prev Close
6.1252 5.28 6.17 6.02 5.92
Bid Price Ask Price Spread News
6.00 6.09 0.09 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
44,972 9,166,736 $ 5.76 $ 52,774,391 7,752,560 1.08 - 24.90
Last Trade Time Type Quantity Stock Price Currency
19:59:22 9 $ 6.09 USD

Vaxart Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 667.76M 109.47M 83.54M $ 9.86M $ - -0.79 -59.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Vaxart News

Date Time Source News Article
3/05/202116:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
3/03/202109:49Seeking AlphaVaxart CEO defends oral COVID-19 vaccine, but shares fall 8%..
2/25/202117:42Seeking AlphaVaxart EPS misses by $0.07, misses on revenue
2/25/202116:22Edgar (US Regulatory)Annual Report (10-k)
2/25/202116:05Edgar (US Regulatory)Current Report Filing (8-k)
2/04/202115:26TipRanksVaxart Stock Takes a Hit, but Is It Warranted? Analyst..
2/04/202103:12TipRanksVaxart Tanks 58% On Oral COVID-19 Vaccine Early Trial Data;..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VXRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.337.825.286.667,349,091-1.23-16.78%
1 Month8.669.945.287.9112,761,634-2.56-29.56%
3 Months7.3424.905.2810.1015,875,613-1.24-16.89%
6 Months5.54524.903.508.2516,773,1430.55510.01%
1 Year2.1824.901.088.1417,016,3453.92179.82%
3 Years5.2624.900.25437.246,657,7410.8415.97%
5 Years17.2724.900.25437.264,144,994-11.17-64.68%

Vaxart Description

Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus.
Your Recent History
NASDAQ
VXRT
Vaxart
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210306 02:36:19